INNOSPEC INC. (IOSP) stock intrinsic value fair value estimate & owner earnings analysis

Innospec is a specialty chemicals formulator organized in three segments: Performance Chemicals (ingredients for personal care, home care, agrochemical and industrial customers), Fuel Specialties (additives that improve combustion efficiency and reduce emissions in diesel, marine, jet and other fuels — including a niche, high-margin product, AvGas, where the company is the world's only producer of the lead additive still used in piston aircraft fuel), and Oilfield Services (chemicals for drilling, completion and production, sold mostly to exploration and production companies). We build value from owner earnings — operating cash flow after removing the swings caused by working-capital timing and stock compensation, and after removing only the portion of capital spending that funds growth rather than the upkeep of existing plants. Over the last ten fiscal years this has produced a median of about $4.56 per share, which we use as the normalized starting point for the valuation rather than a single recent year, because the business genuinely moves through a cycle: Oilfield Services results swing with exploration and production spending (its revenue roughly doubled from 2020 to a 2023 peak of $691 million, then fell to $395 million in 2025 as drilling activity cooled), while Performance Chemicals has grown steadily and now provides the largest, most stable source of profit. Owner earnings actually declined about 16% in the most recently completed year, driven by the Oilfield Services downturn, and interim results so far in 2026 show continued softness there, so our base case does not assume an immediate rebound — the first year of our forecast reflects a further step down before growth resumes. Our base case assumes Oilfield Services stabilizes at its lower level over the next two to three years while Performance Chemicals keeps compounding at a mid-single-digit pace, producing modest overall growth through the middle of the next decade. A specific, dated item then works against the business: aviation-industry and regulatory bodies (the EPA/FAA-backed EAGLE initiative) have targeted eliminating leaded aviation fuel in the United States by the end of 2030, with EU authorizations for the company's product extending only to 2032. We do not know exactly how large this product line is within Fuel Specialties, but because it is unusually profitable, we treat its phase-out as a temporary drag on growth in the 2030-2032 window rather than assuming it continues forever, and beyond that we value the remaining business — which does not depend on any single dated product — as a flat, no-growth earnings stream, since further growth would require reinvestment beyond what is already charged against earnings. On that basis we estimate the shares are worth roughly $87 today. About 62% of that value comes from the years after 2035, which is a meaningful share resting on the assumption that Performance Chemicals and Fuel Specialties (excluding the legacy aviation fuel product) can sustain their current earnings power indefinitely without further growth investment. Our bear case assumes the Oilfield Services slump persists for longer, Performance Chemicals growth slows as raw-material costs and competition weigh on margins, and the aviation fuel phase-out arrives earlier and more completely than regulators have currently indicated. That produces a value of roughly $51 per share — still comfortably positive, because Innospec carries no long-term debt and holds a substantial, growing cash balance, so there is no leverage magnifying the downside. Our bull case assumes Oilfield Services recovers toward its prior cyclical peak, Performance Chemicals keeps its recent double-digit growth pace, and the aviation fuel deadline slips further out as it has historically for aviation fuel transitions, together worth roughly $138 per share. Given the spread between these outcomes, the margin-of-safety price is around $63, a meaningful discount to our base-case estimate that takes account of the downside case. The main things that would prove this estimate wrong on the downside: a deeper or longer oil-and-gas capital spending downturn than we've assumed, or a faster loss of the aviation fuel business than current regulatory timelines suggest. We could not find a public breakdown of exact aviation-fuel product revenue within Fuel Specialties in the filings, so we sized its effect qualitatively rather than with a precise figure — this is the single largest source of uncertainty in the valuation.